Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2006;37:2445
Published online before print September 7, 2006, doi: 10.1161/01.STR.0000244060.83388.76
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/10/2445    most recent
01.STR.0000244060.83388.76v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Swanson, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Swanson, R. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*IRON
*OXYGEN
Related Collections
Right arrow Acute Cerebral Hemorrhage
Right arrowRelated Article

(Stroke. 2006;37:2445.)
© 2006 American Heart Association, Inc.


Editorials

Intracerebral Hematoma

Beyond the Mass Lesion

Raymond A. Swanson, MD

From the Department of Neurology, University of California, San Francisco, and Veterans Affairs Medical Center, San Francisco, Calif.

Correspondence to Raymond A. Swanson, Department of Neurology, Veterans Affairs Medical Center, 4150 Clement St, San Francisco, CA 94121. E-mail raymond.swanson@va.gov


Key Words: intracranial hemorrhage • mitochondria


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

See related article, pages 2457–2462.

The signs and symptoms of acute intracranial hemorrhage are those of a rapidly developing mass lesion, compounded over time by surrounding edema, and sometimes by brain herniation. These are dramatic, debilitating, and often fatal events, but does the pathophysiology of intracranial hemorrhage extend beyond that of mass effect? Blood contains several factors that are potentially, and in some cases definitively, neurotoxic. Chief among these are hemoglobin and its breakdown products, heme and iron, which exhibit neurotoxicity at low micromolar concentrations through mechanisms involving iron-catalyzed production of reactive oxygen species.1,2 Brain has a variety of defense mechanisms to prevent the formation of reactive iron from blood hemoglobin, including inducible and constitutive heme oxygenases and iron-binding proteins,3 but these are easily overwhelmed by frank hemorrhage.4 Indirect evidence for hematoma toxicity on surrounding brain has come from studies showing reduced extraction of blood oxygen by perihematoma brain tissue.5 Given that heme and iron are potent mitochondrial toxins, one explanation for reduced oxygen extraction in the vicinity of a brain hematoma is a reduced capacity for oxygen use by mitochondria in this region.

The study by Kim-Han et al6 provides additional support for this idea. This study measured rates of oxygen use by mitochondria isolated from the margins of intracerebral hematomas in 6 human subjects. These measurements revealed a roughly 40% reduction in state 3 respiration and 3-fold increase in state 4 respiration in perihematoma samples, relative to putatively normal mitochondria taken from epilepsy surgery sites. State 3 . . . [Full Text of this Article]


Related Article:

Perihematomal Mitochondrial Dysfunction After Intracerebral Hemorrhage
Jeong Sook Kim-Han, Sarah J. Kopp, Laura L. Dugan, and Michael N. Diringer
Stroke 2006 37: 2457-2462. [Abstract] [Full Text] [PDF]